Morgan Stanley analyst Thibault Boutherin Upgrades Novartis (NOVN:SW) (NYSE: NVS) to Overweight from Equal-weight and raised price target to CHF115.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE